Co-Authors
This is a "connection" page, showing publications co-authored by Paul Moss and Gokhan Tut.
Connection Strength
1.322
-
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study. Lancet Healthy Longev. 2021 Sep; 2(9):e544-e553.
Score: 0.963
-
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis. Lancet Healthy Longev. 2021 Sep; 2(9):e554-e560.
Score: 0.240
-
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Lancet Infect Dis. 2021 11; 21(11):1529-1538.
Score: 0.060
-
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study. Lancet Healthy Longev. 2021 Jun; 2(6):e362-e370.
Score: 0.059